Media Update: Pediatric research at ReSViNET 2023 underscores Beyfortus’ potential to prevent RSV disease in infants

https://ift.tt/vXgI6lm

Pediatric research at ReSViNET 2023 underscores Beyfortus’ potential to prevent RSV disease in infants



from Sanofi - Aventis Groupe https://ift.tt/oBmTvA4
via IFTTT

Post a Comment

0 Comments